| Eli Lilly (Suisse) SA - Taltz 40 mg, solution injectable en seringue préremplie |
| 65906 | | 02 | | Taltz 40 mg | | solution injectable en seringue préremplie | | L04AC13 | | Ixekizumab | | 22.01.2026 | | |
|
| Composition |
| ixekizumabum 40 mg, saccharum, polysorbatum 80, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 0.0505 mg. |
| Packungsbestandteile |
| solution injectable en seringue préremplie | | | | | | Active Agent | Dose |
|---|
| Ixekizumabum | 40mg / 0.5ml |
| | | | Inactive agents |
|---|
| Natrii Hydroxidum ad Ph | | Polysorbatum 80 | | Saccharum |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | | | | B | | Yes |
|
